These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2709652)

  • 1. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bactericidal activity of antituberculosis drugs against Mycobacterium avium complex].
    Tsukamura M
    Kekkaku; 1990 Jan; 65(1):9-12. PubMed ID: 2313966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs].
    Tsukamura M
    Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In-vitro combined effect of antituberculosis drugs on Mycobacterium avium complex].
    Tsukamura M; Yamori S
    Kekkaku; 1990 Apr; 65(4):257-62. PubMed ID: 2376931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains].
    Tsukamura M; Yamori S
    Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interrelationship among colonial morphology, susceptibility to antituberculosis drugs, growth rate, and viability in Dubos liquid medium in Mycobacterium avium complex strains].
    Tsukamura M
    Kekkaku; 1989 Dec; 64(12):753-9. PubMed ID: 2615130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cross-resistance relationship between streptomycin and kanamycin resistances in Mycobacterium smegmatis (strain Jucho)--comparison of the development patterns of resistances to streptomycin and kanamycin among Mycobacterium tuberculosis, Mycobacterium avium complex, and Mycobacterium smegmatis].
    Tsukamura M
    Kekkaku; 1990 Dec; 65(12):785-9. PubMed ID: 2127614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
    Tsukamura M
    Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiology of resistance to antituberculosis drugs in Mycobacterium tuberculosis complex strains isolated from adenopathies in Djibouti. Prospective study carried out in 1999].
    Koeck JL; Bernatas JJ; Gerome P; Fabre M; Houmed A; Herve V; Teyssou R
    Med Trop (Mars); 2002; 62(1):70-2. PubMed ID: 12038183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM].
    Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K
    Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains.
    Tsukamura M; Miyachi T
    Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing].
    Tsukamura M
    Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen].
    Shigeto E; Taska H
    Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of clarithromycin-sensitive and clarithromycin-resistant Mycobacterium avium strains isolated from AIDS patients during therapy regimens including clarithromycin.
    Matsiota-Bernard P; Zinzendorf N; Onody C; Guenounou M
    J Infect; 2000 Jan; 40(1):49-54. PubMed ID: 10762111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In-vitro susceptibility of Mycobacterium avium complex to isoniazid and ethionamide].
    Tsukamura M; Yamori S
    Kekkaku; 1990 Mar; 65(3):243-7. PubMed ID: 2352411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance rates to antituberculous drugs in Sivas province].
    Gönlügür U; Bakici MZ; Gönlügür TE; Hasbek M
    Mikrobiyol Bul; 2007 Jul; 41(3):459-63. PubMed ID: 17933259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that antituberculosis drugs are really effective in the treatment of pulmonary infection caused by Mycobacterium avium complex.
    Tsukamura M
    Am Rev Respir Dis; 1988 Jan; 137(1):144-8. PubMed ID: 3337455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].
    Truffot-Pernot C; Giroir AM; Maury L; Grosset J
    Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
    Heifets L
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
    Yamori S; Ichiyama S; Shimokata K; Tsukamura M
    Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.